Paper Details
- Home
- Paper Details
Adherence to cholinesterase inhibitors in Alzheimer's disease: a review.
Author: BradyRoseanna, WeinmanJohn
Original Abstract of the Article :
BACKGROUND/AIMS: Treatment adherence is a major problem in numerous medical conditions, and is a particular challenge in patients with Alzheimer's disease (AD). METHODS: This non-systematic review summarises the current literature on factors that affect adherence to cholinesterase inhibitors, the m...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1159/000347140
データ提供:米国国立医学図書館(NLM)
Adherence in the Alzheimer's Desert: A Challenging Journey
Alzheimer's disease is a complex and debilitating condition that presents significant challenges for patients and their caregivers. This review examines the issue of adherence to cholinesterase inhibitors, a mainstay treatment for Alzheimer's disease. The authors explore the factors that influence adherence to these medications, including patient and caregiver beliefs, drug tolerability, physical limitations, and caregiver burden.
Finding Oasis in the Desert of Alzheimer's Care
The review emphasizes the importance of addressing caregiver concerns to improve adherence to medications. The authors discuss potential interventions to enhance adherence, such as educational programs and new drug delivery methods. This research underscores the need for comprehensive strategies to support patients with Alzheimer's disease and their caregivers, helping them navigate the challenges of this condition.
A Path Through the Alzheimer's Desert
This research, like a guidebook for a desert journey, provides insights into the complexities of adherence to medications in Alzheimer's disease. It highlights the importance of understanding patient and caregiver needs and developing strategies to enhance adherence, ultimately leading to improved care and quality of life.
Dr.Camel's Conclusion
This review provides a valuable perspective on the challenges of adherence to cholinesterase inhibitors in Alzheimer's disease, emphasizing the need for tailored strategies to support both patients and their caregivers in this challenging journey. It reminds us that even in the vast and unforgiving desert of Alzheimer's, there are pathways to improved care and quality of life.
Date :
- Date Completed 2013-12-23
- Date Revised 2022-03-09
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.